Rubric Capital Management LP 13D and 13G filings for ARS Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:08 pm Purchase | 2026-03-31 | 13G | ARS PHARMACEUTICALS, INC SPRY | Rubric Capital Management LP | 8,000,000 8.060% | 1,800,000 (+29.03%) | Filing |
| 2026-02-13 4:24 pm Purchase | 2025-12-31 | 13G | ARS PHARMACEUTICALS, INC SPRY | Rubric Capital Management LP | 6,200,000 6.270% | 6,200,000 (New Position) | Filing |